We would love to hear your thoughts about our site and services, please take our survey here.
All looking extremely good here...
https://www.legalsportsbetting.com/news/senator-bill-dodd-ca-to-invest-the-revenue-from-sports-betting/
https://www.legalsportsreport.com/41729/sports-betting-news-june-8-2020/
https://twitter.com/WreckT4ngle
Is because the committee voted 9 to 3 for this to go to the senate on Tuesday evening. 9 to 3, thats an overwhelming positive and I don't see this not being passed.
California need this badly and will add billions to their pot. I'm sure some back handers have been passed around too, to get this through.
No brainer here.. Buy all day long..
https://www.legalsportsreport.com/41316/new-california-sports-betting-bill/
https://www.investegate.co.uk/physiomics-plc--pyc-/rns/conference-attendance-and-presentation/202004281450012019L/
Dr Jim Millen, CEO said : "In these difficult times, it's great to see that lifescience companies can find creative ways to continue to develop the relationships needed to fight COVID-19, cancer and other diseases where new treatments are desperately needed. We look forward to fully participating in the digital version of this popular conference."
Mon, 23rd Mar 2020 14:59
RNS Number : 2531H
Tekcapital plc
23 March 2020
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.
23 March 2020
Tekcapital plc
("Tekcapital" or the "Company")
Portfolio Company Update
New FDA Guidance to Expand the Availability of Respiratory Devices
Tekcapital plc, (AIM: TEK) the UK intellectual property investment group focused on creating marketplace value from investing in university technology, notes that the United States Food and Drug Administration (the "FDA") has issued a new policy designed to expand the availability of respiratory devices, including Oxygen Concentrators, during the COVID-19 Pandemic which is potentially relevant to its portfolio company Belluscura plc.
A copy of the FDA announcement may be found here.
About Belluscura plc
Belluscura is focused on developing novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Belluscura is developing innovative enriched oxygen treatment platforms that reduce the cost of treatment and increase available treatment options. To learn more about Belluscura, please visit www.belluscura.com.
Tekcapital owns 18.9% of the share capital of Belluscura.
Clifford M. Gross Ph.D., Executive Chairman of Tekcapital plc commented:
"We are very glad to see that the FDA is moving expeditiously to facilitate the supply of respiratory devices during the COVID-19 pandemic. "
https://www.share-talk.com/share-talk-bulletin-board-heroes-monday-16th-march-2020/
What worth 36 mil MCAP?
Most is in sticky PI hands